Rapid identification of JAK2 exon 12 mutations using high resolution melting analysis.
about
Jak2 inhibitors: rationale and role as therapeutic agents in hematologic malignancies.Interlaboratory development and validation of a HRM method applied to the detection of JAK2 exon 12 mutations in polycythemia vera patients.Detection of exon 12 Mutations in the JAK2 gene: enhanced analytical sensitivity using clamped PCR and nucleotide sequencing.High-resolution DNA melting analysis in clinical research and diagnostics.A highly sensitive quantitative real-time PCR assay for determination of mutant JAK2 exon 12 allele burdenThe JAK2 exon 12 mutations: a comprehensive review.The mutation profile of JAK2 and CALR in Chinese Han patients with Philadelphia chromosome-negative myeloproliferative neoplasms.Nested high-resolution melting curve analysis a highly sensitive, reliable, and simple method for detection of JAK2 exon 12 mutations--clinical relevance in the monitoring of polycythemia.Rapid detection of KIT mutations in core-binding factor acute myeloid leukemia using high-resolution melting analysisMolecular diagnosis of myeloproliferative neoplasms.The role of molecular genetic analysis within the diagnostic haemato-oncology laboratory.Molecular diagnosis of leukemia.Laboratory Investigation of Myeloproliferative Neoplasms (MPNs): Recommendations of the Canadian Mpn Group.JAK2 V617F mutation in myelodysplastic syndrome, myelodysplastic syndrome/myeloproliferative neoplasm, unclassifiable, refractory anemia with ring sideroblasts with thrombocytosis, and acute myeloid leukemia.High resolution melting analysis for JAK2 Exon 14 and Exon 12 mutations: a diagnostic tool for myeloproliferative neoplasms.Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations.CEBPA gene mutational status: a complete screening using high-resolution melt curve analysis.CALR, JAK2 and MPL mutation status in Argentinean patients with BCR-ABL1- negative myeloproliferative neoplasms.Clinical course and molecular features in 21 patients with atypical chronic myeloid leukemia.The Prevalence of JAK2, MPL, and CALR Mutations in Chinese Patients With BCR-ABL1-Negative Myeloproliferative Neoplasms.
P2860
Q33586552-1BF661E2-4BA9-4BE3-BCEA-CBAE529DA1D2Q33609532-D8AED17E-779D-407D-AC0C-4E69D8B77818Q33813824-7243F4B8-46BE-4EA7-A451-B7256A9E9245Q34102903-1A0048C5-81F2-41F1-9D2F-A8BA63EE5305Q34189794-7FD8AECF-4FF7-44F3-9906-0350071A352FQ34192739-18C68240-1C84-474E-996E-B39000E215AEQ34467863-6C2DA67F-FE37-4085-8DE7-6CE511A39328Q34801247-B0AC420B-3A32-428C-BB22-2BA4CB24627DQ37313002-A136AC07-9950-475F-ADC8-CE1D9F365B44Q37542270-2289CF73-D0D3-4DE6-B94B-A98A2D1AD8AFQ37924989-47D1DF14-F77E-4549-AA1F-796DBDD082ACQ38018998-8A67AFBA-A931-4D2A-9AAD-7AA2395AB00AQ38816384-DF7AD763-ED88-4EB6-9ADC-38974B93C54BQ41898628-0F754426-3E67-41C6-9A93-24A49C71B940Q41902113-3B970DAD-989C-4378-BCC5-441392193A2DQ43979129-7F905A81-54D1-4470-B53A-F1610D81E9C5Q44786876-7DF28AF9-F4E6-421D-8829-A371B4921A57Q48223642-BB297DB8-49FC-4053-BA6A-530EE8C325B6Q54578704-9DD90458-449C-4607-8A9D-C7E2BE8ACF51Q55056597-BD9CE1F7-53B2-451A-8902-DB48F0223B14
P2860
Rapid identification of JAK2 exon 12 mutations using high resolution melting analysis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Rapid identification of JAK2 exon 12 mutations using high resolution melting analysis.
@en
Rapid identification of JAK2 exon 12 mutations using high resolution melting analysis.
@nl
type
label
Rapid identification of JAK2 exon 12 mutations using high resolution melting analysis.
@en
Rapid identification of JAK2 exon 12 mutations using high resolution melting analysis.
@nl
prefLabel
Rapid identification of JAK2 exon 12 mutations using high resolution melting analysis.
@en
Rapid identification of JAK2 exon 12 mutations using high resolution melting analysis.
@nl
P2093
P356
P1433
P1476
Rapid identification of JAK2 exon 12 mutations using high resolution melting analysis.
@en
P2093
Amy V Jones
Anthony R Green
Helen E White
P304
P356
10.3324/HAEMATOL.12883
P577
2008-08-12T00:00:00Z